MedTrace Logo

Clinical Response of Nuberol Forte in Chronic Neck Pain in Routine Rehabilitation Centers

NCT06628466 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-10-08

No results posted yet for this study

Summary

Globally, the prevalence of neck pain ranges from 16.7% to 75.1%. Despite conducting multiple studies on specific subject pools in Pakistan, primarily focusing on professional-related neck pain, there is a lack of accurate data to determine the local prevalence of neck pain or the effective management of neck pain through physical therapy and pharmacological intervention. The purpose of this study is to evaluate the clinical effectiveness of paracetamol and orphenadrine (Nuberol Forte) when combined with physical therapy in Pakistani patients suffering from neck pain at regular rehabilitation centers.

Conditions

  • Chronic Neck Pain

Interventions

DRUG

Nuberol Forte

Quality of Life study

Sponsors & Collaborators

  • The Searle Company Limited Pakistan

    lead INDUSTRY

Principal Investigators

  • Zahoor Ahmed, Neurologist · Karachi medical Complex, Karachi

  • Ali Hassan, Neurologist · Ziauddin Hospital, Karachi

  • Sonober Jawaid, Neurologist · Al-Maisarah Hospital, Karachi

  • Muhammad Y Ahmedani, FCPS · Baqai Hospital, Karachi

  • Ghufranullah Khan, Surgeon · Tabba Heart, Karachi

  • Jai S Rana, Neurologist · Poly Medical & Dental Clinic, Karachi

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-25
Primary Completion
2023-12-20
Completion
2024-01-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06628466 on ClinicalTrials.gov